Significance of OCT3/4 and SOX2 antigens expression by leukemic blast cells in adult acute leukemia.
Salah ArefOmnyia KhaledNadia El MenshawyEmad AzmyMohamed ArefOsama SalamaNada Khaled
Published in: Journal of the Egyptian National Cancer Institute (2024)
Our findings indicated that both SOX2 and OCT3/4 could serve as biomarkers that could improve risk stratification of acute leukemia patients. Also, both SOX2 and OCT3/4 might be a therapeutic target, especially in resistant acute leukemia.